TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
AUPH

Aurinia Pharmaceuticals Inc

Healthcare · Biotechnology

16.90$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Aurinia Pharmaceuticals Inc (AUPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 752 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AUPH
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
52 34 57 190 146 324 464 543 471 548 551 752
34 17 41 175 133 315 419 513 443 425 447 492
23 5.8 40 166 118 306 272 232 94 49 83 80
33 16 40 173 126 306 398 466 389 350 358 398
0.1 0.0 0.1 0.1 0.2 0.4 0.1 15 13 24 37 41
0.0 -0.1 14 19 25 40 39 46
0.1 0.0 0.0 0.0 0.0 0.1 4.8 9.8 8.6
18 17 16 14 13 8.9 9.3 8.4 6.4 5.0 4.4 3.8
7.3 14 21 24 33 26 56 64 65 170 173 170
2.8 3.6 7.9 8.2 7.3 11 32 41 46 77 98 94
2.9 4.1 0.1 6.9 0.8 1.1 0.9 16 15 18
1.4 2.1 2.9 3.8 7.1 4.2 2.6 3.9 3.1 4.3 5.2 3.3
11 5.5 9.1 12
45 20 36 166 113 299 408 479 405 378 377 581
-236 -258 -281 -352 -416 -472 -575 -756 -864 -942 -937 -649
29 32 35 77 85 93 118 129 142 143 146 139

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?